HGERS
JAZZ icon

Householder Group Estate & Retirement Specialist’s Jazz Pharmaceuticals JAZZ Stock Holding History

Householder Group Estate & Retirement Specialist’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$0 Hold
3
– – ﹤0.01% 885
2024
Q3 		$0 Buy
+3
New +$329 ﹤0.01% 1249
2024
Q2 		– Sell
-3
Closed -$361 – 1275
2024
Q1 		$361 Hold
3
– – ﹤0.01% 1181
2023
Q4 		$0 Hold
3
– – ﹤0.01% 1242
2023
Q3 		$388 Buy
+3
New +$400 ﹤0.01% 1198
2023
Q1 		$0 Sell
3
-7
-70% -$1.03K ﹤0.01% 1271
2022
Q4 		$1K Sell
10
-8
-44% -$1.17K ﹤0.01% 340
2022
Q3 		$2K Buy
+18
New +$2.74K ﹤0.01% 963

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Householder Group Estate & Retirement Specialist's JAZZ Position: Q4 2024 in Review

Householder Group Estate & Retirement Specialist held its Jazz Pharmaceuticals (JAZZ) position steady in Q4 2024 at 3 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #885.

Householder Group Estate & Retirement Specialist first reported a position in JAZZ in Q3 2022 and has held it in 8 quarters since. The position peaked at $2K in Q3 2022. 508 funds tracked by Wall St. Rank hold JAZZ as of Q4 2024.

  • Householder Group Estate & Retirement Specialist held 3 shares of Jazz Pharmaceuticals worth $0 as of Q4 2024.
  • Householder Group Estate & Retirement Specialist left its Jazz Pharmaceuticals share count unchanged in Q4 2024.
  • Jazz Pharmaceuticals made up ﹤0.01% of Householder Group Estate & Retirement Specialist's portfolio in Q4 2024, its #885 holding.
  • Householder Group Estate & Retirement Specialist first reported a position in Jazz Pharmaceuticals in Q3 2022 and has held it in 8 quarters since.
  • Householder Group Estate & Retirement Specialist's Jazz Pharmaceuticals position peaked at $2K in Q3 2022.
  • 508 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2024.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q4 2024, filed 15 Jan 2025.